Grand Ballroom
2017-10-21

08:30-10:00 Session 5. Innovation in interstitial lung diseases

Chairman: A Wells  Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, United Kingdom , Taihua Wu  The First Affiliated Hospital of Dalian Medical University

NO. Time Type Subject Speaker Organization
1 08:30-09:00 Symposium

IIP Classification: update and new entities (ACIF, PPFE, etc)

A Wells

Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, United Kingdom

2 09:00-09:30 Symposium

New diagnostic approaches for ILD (including cryo, EBUS, etc.)

Sara Tomassetti

Department of Diseases of the Thorax, GB Morgagni Hospital, Forlì, Italy

3 09:30-10:00 Symposium

New treatment modalities for IPF

P Spagnolo

Section of Respiratory Diseases, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, 35128 Padova, Italy

10:30-12:00 Session 6. Idiopathic pulmonary fibrosis

Chairman: F Bonella  Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany , Wen Ning  Nankai University, Tianjin, 300071, China

NO. Time Type Subject Speaker Organization
1 10:30-11:00 Symposium

IPF pathogenesis: How UIP develops

Wen Ning

Nankai University, Tianjin, 300071, China

2 11:00-11:30 Symposium

IPF: Early diagnosis and staging

F Bonella

Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany

3 11:30-12:00 Symposium

Comorbidities in Idiopathic Pulmonary Fibrosis

Huaping Dai

China-Japan Friendship Hospital

13:00-14:00 Poster Discussion 2

Chairman: Xiaoming Cheng  Xinqiao Hospital of Third Military Medical University , Mengshu Cao  Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing Univeristy Medical School , Wanli Ma  Department of pathophysiology, Tongji Medical College, Huazhong University of Science and Technology , Carlos Robalo Cordeiro  Coimbra University Hospital

NO. Time Type Subject Speaker Organization
1 13:00-13:05 Poster Discussion

The role of IL-17A in murine model of Acute exacerbation of pulmonary fibrosis by HSV1 infection

Tao Chen

Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai, China

2 13:05-13:10 Poster Discussion

Effect of G-CSF on Bone Marrow Mesenchymal Stem Cells inhibits biological activity of  Fibroblasts by paracrine function

Feiyan Zhao

Xiangya School of Medicine, Central South University

3 13:10-13:15 Poster Discussion

Loss of Fstl1 in lung mesenchymal cells alleviates bleomycin-induced lung fibrosis in mice

Si Zhang

Nankai University

4 13:15-13:20 Poster Discussion

Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis ------ Comparision with Idiopathic Pulmonary Fibrosis

Mengshu Cao

Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing Univeristy Medical School

5 13:20-13:25 Poster Discussion

Modeling Alveolar Injury using Microfluidic Co-cultures for Monitoring Bleomycin-induced Epithelial/Fibroblastic Cross-talk Disorder

Jiarui He

Department of Pulmonary and Critical Care Medicine, Center for Respiratory Diseases, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases, Beijing, China

6 13:25-13:30 Poster Discussion

The role of infection in acute exacerbation of Idiopathic Pulmonary Fibrosis

Dong Weng

Shanghai Pulmonary Hospital

7 13:30-13:35 Poster Discussion

Sodium Tanshinone IIA Sulfonate Inhibit the Proliferation of Hypoxia-Induced PASMCs and Its Mechanism

Jinxu Zheng

Affiliated Hospital of Jiangsu University

8 13:35-13:40 Poster Discussion

Predisposition of MUC5B rs35705950 minor allele to Rheumatoid Arthritis associated Interstitial Pneumonitis: a step forward to molecular endotyping of pulmonary fibrosis

Annette Van Der Vis

St Antonius Hospital

9 13:40-13:45 Poster Discussion

Serum Fstl-1 as a diagnostic marker for idiopathic pulmonary fibrosis

Jing Geng

China-Japan Friendship Hospital

10 13:45-13:50 Poster Discussion

Real-life experience with pirfenidone in idiopathic pulmonary fibrosis

Yongji Yan

Department of Occupational Medicine and Toxicology, Beijing Chaoyang Hospital, Capital Medical University

11 13:50-13:55 Poster Discussion

MUC5B influence on the prognosis of IPF

Huifang Song

Inner mongolia peoples hospital

12 13:55-14:00 Poster Discussion

ILD biobanking to characterize disease development in ILD subgroups

Marjolijn Struik

St Antonius Hospital

14:00-15:30 Session 7. Environmental and occupational ILD

Chairman: M Drent  St. Antonius Hospital , Luqing Wei  Tianjin Armed Police Hospital

NO. Time Type Subject Speaker Organization
1 14:00-14:30 Symposium

Occupational ILDs in China

Qiao Ye

Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

2 15:00-15:30 Symposium

Pharmogenetics and their impact on drug induced interstitial lung disease

M Drent

St. Antonius Hospital

3 14:30-15:00 Symposium

Chronic hypersensitivity pneumonitis

U. Costabel

Ruhrlandklinik University Hospital, University of Duisburg-Essen

16:00-18:00 Session 8. Special session

Chairman: Shinichiro Ohshimo  Hiroshima University , Yabin Zhao  The First Affiliated Hospital of China Medical University

NO. Time Type Subject Speaker Organization
1 16:00-16:30 Symposium

Diffuse panbronchiolitis

Jian Kang

The First Hospital of China Medical University

2 16:30-17:00 Symposium

Diffuse alveolar hemorrhage: causes and management

Carlos Robalo Cordeiro

Coimbra University Hospital

3 17:00-17:15 Oral Presentation

FUNCTIONAL POLYMORPHISMS IN THE NFE2L2 GENE ARE ASSOCIATED WITH TUBERCULOSIS SUSCEPTIBILITY

Miaomiao Zhang

West China Hospital,Sichuan University

4 17:15-17:30 Oral Presentation

Radiographic Patterns in a cohort of 281 asbestosis patients Objectives

Xiaoli Yang

Beijing Chaoyang Hospital affiliated to Capital Medical University

5 17:30-17:45 Oral Presentation

A 40-YEAR STUDY OF 640 CONSECUTIVE PATIENTS WITH SARCOIDOSIS AT A TERTIARY REFERRAL CENTER IN BARCELONA, SPAIN

Juan Maria Maná Rey

Hospital Universitari de Bellvitge

6 17:45-18:00 Oral Presentation

A NEW SARCOIDOSIS DIAGNOSTIC SCORE (SDS)

Robert Baughman

University of Cincinnati, Cincinnati, OH USA